<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/40E23D5D-D55B-4F07-AF6C-1EA32F5E8C43"><gtr:id>40E23D5D-D55B-4F07-AF6C-1EA32F5E8C43</gtr:id><gtr:firstName>Ken</gtr:firstName><gtr:surname>Suzuki</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600872"><gtr:id>0EC95F5D-9350-4B03-9E00-B7DE3297CB77</gtr:id><gtr:title>Facilitation of collaboration with Professor N Rosenthal: Study of the role of IGF-1 in cell therapy for heart failure</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600872</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Post-infarction heart failure remains a major cause of human disability and death, and development of efficient cost-effective strategies is a high priority. Recent research has repeatedly indicated that skeletal myoblast transplantation is a promising strategy. However, importantly, there remain several fundamental issues to be resolved by laboratory research for the future success of this emerging treatment. These include unclear mechanisms of the therapeutic effects and insufficient graft ability. Such information is essential to define the most effective, safest protocol of the treatment and to further refine it. With support from an MRC Fellowship, I have been actively investigating these issues through studying the behaviour of grafted myoblasts in the cardiac environment at cellular, biochemical, and molecular levels. Current data from my own and other laboratories demonstrated that the ability of grafted skeletal cells to survive within the myocardium, transdifferentiate into cardiomyocytes and/or form intercellular connections with host cardiomyocytes is largely limited. This suggests an important role of the paracrine effect in the therapeutic benefits. More recent evidence obtained from our own experiments has given a rise to a strong, original hypothesis that IGF-1 is a central player in myoblast transplantation-induced paracrine effects. IGF-1 is likely to induce a variety of beneficial effects on every component of the failing myocardium including cardiomyocytes, vasculature, and ECM. IGF-1 is also known to enhance myocardial regeneration by amplifying recruitment of endogenous stem or progenitor cells. Further, enhancement of IGF-1 expression by transplanting myoblasts genetically modified to overexpress IGF-1 (cell-based IGF-1 therapy) may augment the therapeutic efficacy of myoblast transplantation. Addition of these studies, which fits very well to our previous and ongoing projects under the Fellowship, will enable my research to be more complete and provide greater understanding of cell therapy for treating heart failure. This application seeks to support for establishing collaboration with Professor Nadia Rosenthal at European Mouse Biology Laboratory, Italy, who is a leading scientist in muscle regeneration and IGF-1 research which are closely related and complementary to my research. This collaboration will greatly help with the effective, successful completion of the project. She will be able to provide valuable scientific advice and guidance, together with useful strains of transgenic animal. My expertise in heart research will, in turn, be useful for her to expand her research areas. Exchange and fusion of our expertise through the proposed collaboration will open the door to interesting new research areas.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-03</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>790167</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Heart &amp; Lung Institute (NHLI)</gtr:department><gtr:description>Prof Nadia Rosenthal</gtr:description><gtr:id>57924D29-81BA-401A-B0CA-99EC277EA35E</gtr:id><gtr:impact>MRC Collaboration grant, resulted in publications in top journals (Circulation, Circulation Research).</gtr:impact><gtr:outcomeId>ne2zhbZnjTA-1</gtr:outcomeId><gtr:partnerContribution>Exchange of research expertise</gtr:partnerContribution><gtr:piContribution>Exchange of research expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>WHRI open seminar 2007</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>79C053AB-B6C1-46B4-9DE6-60B930230BDE</gtr:id><gtr:impact>William Haarvey Research Intitute Cardiovascular Stem Cell Conference attended by 200 audiences including basic scientists, clinicians and lay people. 1 day conference.

wide dissemination of the research among scientists, clinicians, and lay people.</gtr:impact><gtr:outcomeId>C4C75301BA9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WHRI open seminar 2008</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3AAC1B05-7866-4D56-A56B-FF567871D902</gtr:id><gtr:impact>The second William harvey Research Intitute Cardiobvascular Stem Cell Conference attended by 100 clinicans and basic scientists. A half day course. 45 min talk was given.

wide dissemination of the resaerch among scientists, clinicians and lay people.</gtr:impact><gtr:outcomeId>E108BF2ADD8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Barts Charity (start-up)</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Barts Charity</gtr:fundingOrg><gtr:id>6647044F-91EB-46CE-989C-42880B8493C3</gtr:id><gtr:outcomeId>BC9999DE8F00</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>311054</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC (Shintani NIRG)</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1000461</gtr:fundingRef><gtr:id>EF80EE83-F6EF-4505-8770-0C098CF67608</gtr:id><gtr:outcomeId>DDz4iCBB6om</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>223142</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR-NEAT (sheet)</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>NEAT L018</gtr:fundingRef><gtr:id>399B9ADB-B05B-4B2F-AB6D-E87808010F72</gtr:id><gtr:outcomeId>jRV3854hZ3q</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>240000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Clinical Research Training Fellowship</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>A2FDE16D-1E38-4D46-9EC8-BA2C93AE19A0</gtr:id><gtr:outcomeId>8B231250D180</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F43A1949-B786-452D-BD24-B1626095BB6C</gtr:id><gtr:title>A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d6846c570a3ee22b45ee7365713a7a"><gtr:id>05d6846c570a3ee22b45ee7365713a7a</gtr:id><gtr:otherNames>Lara-Pezzi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>E71D8AF2791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0ED9977-6C03-44DA-9C75-82F29251414C</gtr:id><gtr:title>Enhancing repair of the mammalian heart.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9323ab2a0a1536da7eaf894632e20a33"><gtr:id>9323ab2a0a1536da7eaf894632e20a33</gtr:id><gtr:otherNames>Santini MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>036F62C5501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15807268-9802-4670-8405-A2D5C7DA7954</gtr:id><gtr:title>The future of regenerative therapy in patients with chronic heart failure.</gtr:title><gtr:parentPublicationTitle>Nature clinical practice. Cardiovascular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f753e0df1405b6af326b572e7621e8"><gtr:id>64f753e0df1405b6af326b572e7621e8</gtr:id><gtr:otherNames>Yacoub M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1743-4297</gtr:issn><gtr:outcomeId>0086E700AD0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EA052AF-AA7D-48DB-8414-71D44A8D9854</gtr:id><gtr:title>Calcineurin splicing variant calcineurin A?1 improves cardiac function after myocardial infarction without inducing hypertrophy.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b52c027f944395e859c7fe9341d215d"><gtr:id>6b52c027f944395e859c7fe9341d215d</gtr:id><gtr:otherNames>Felkin LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>pm_13254_24_21632490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D648C8F9-7CB7-46EF-9A89-276468172422</gtr:id><gtr:title>Antioxidant amelioration of dilated cardiomyopathy caused by conditional deletion of NEMO/IKKgamma in cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9672728d3e581242e93e9a6c66b29eab"><gtr:id>9672728d3e581242e93e9a6c66b29eab</gtr:id><gtr:otherNames>Kratsios P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>B1DBAF4CA40</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600872</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>